Our Latest Features
Check out the latest news about LifeView testing in the media, including in-depth features, press releases, and more.
LifeView In The News
This Baby Was Carefully Selected As An Embryo
New York Times
Polygenic risk scores enable patients and their IVF providers to prioritize embryo transfers with greater precision. Our Embryo Health Score Test is at the forefront of this revolutionary approach, providing deeper genomic insights that refine embryo selection.
Aspiring Parents Have a New DNA Test to Obsess Over
The Atlantic
The Cassidys’ doctor told them about a company, Genomic Prediction, that could assess their potential children’s odds of developing conditions that aren’t tied to a single gene, such as heart disease, diabetes, and schizophrenia. The test wouldn’t be any more invasive than screening for a single gene—all the company needed was an embryo biopsy.
For a long time, the narrative around infertility has primarily focused on women, with limited progress in providing men with actionable insights into their fertility. The test, offers an in-depth analysis of sperm quality and functionality, crucial for understanding male fertility potential.
More
Other Recent Media...
- Genomic Prediction Partners with HelpCureHD
- LifeView PGT Now New York State Licensed
- Genomic Prediction Promotes Kelly Ketterson to Chief Executive Officer
- Ovation Fertility Licenses Genomic Prediction's LifeView PGT
- Genomic Prediction Technology Uncovers New CRISPR Safety Concerns in Human Embryos